Aristotle Capital Boston’s QuidelOrtho QDEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.93M Buy
420,402
+28,498
+7% +$700K 0.43% 92
2025
Q4
$11.2M Buy
391,904
+9,515
+2% +$258K 0.61% 72
2025
Q3
$11.3M Buy
382,389
+146,956
+62% +$4.02M 0.58% 74
2025
Q2
$6.79M Sell
235,433
-16,641
-7% -$492K 0.35% 93
2025
Q1
$8.82M Sell
252,074
-60,566
-19% -$2.47M 0.44% 78
2024
Q4
$13.9M Sell
312,640
-32,759
-9% -$1.34M 0.52% 75
2024
Q3
$15.8M Buy
345,399
+7,848
+2% +$317K 0.52% 73
2024
Q2
$11.2M Sell
337,551
-18,094
-5% -$740K 0.38% 90
2024
Q1
$17M Sell
355,645
-2,205
-0.6% -$129K 0.52% 75
2023
Q4
$26.4M Buy
357,850
+2,341
+0.7% +$158K 0.81% 51
2023
Q3
$26M Buy
355,509
+16,535
+5% +$1.32M 0.84% 49
2023
Q2
$28.1M Buy
338,974
+6,746
+2% +$591K 0.84% 46
2023
Q1
$29.6M Buy
332,228
+13,836
+4% +$1.2M 0.91% 43
2022
Q4
$27.3M Buy
318,392
+41,590
+15% +$3.52M 0.86% 50
2022
Q3
$19.8M Sell
276,802
-20,257
-7% -$1.81M 0.67% 61
2022
Q2
$28.9M Buy
297,059
+14,373
+5% +$1.47M 0.86% 45
2022
Q1
$31.8M Buy
282,686
+10,961
+4% +$1.17M 0.8% 54
2021
Q4
$36.7M Sell
271,725
-6,793
-2% -$945K 0.86% 45
2021
Q3
$39.3M Buy
278,518
+6,616
+2% +$889K 0.92% 40
2021
Q2
$34.8M Sell
271,902
-19,179
-7% -$2.26M 0.8% 49
2021
Q1
$37.2M Sell
291,081
-4,187
-1% -$773K 0.83% 46
2020
Q4
$53M Sell
295,268
-14,667
-5% -$3.26M 1.26% 25
2020
Q3
$68M Sell
309,935
-5,838
-2% -$1.3M 1.97% 4
2020
Q2
$70.7M Sell
315,773
-134,397
-30% -$21.1M 2.15% 4
2020
Q1
$44M Buy
450,170
+6,359
+1% +$514K 1.88% 8
2019
Q4
$33.3M Buy
443,811
+27,729
+7% +$1.79M 0.92% 42
2019
Q3
$25.5M Buy
416,082
+61,037
+17% +$3.67M 0.75% 58
2019
Q2
$21.1M Sell
355,045
-22,882
-6% -$1.37M 0.66% 66
2019
Q1
$24.7M Buy
377,927
+150,375
+66% +$9.1M 0.83% 50
2018
Q4
$11.1M Sell
227,552
-14,921
-6% -$891K 0.91% 51
2018
Q3
$15.8M Sell
242,473
-64,006
-21% -$4.47M 1.16% 31
2018
Q2
$20.4M Sell
306,479
-106,644
-26% -$6.44M 1.62% 10
2018
Q1
$21.4M Buy
413,123
+98,721
+31% +$4.6M 1.01% 39
2017
Q4
$13.6M Sell
314,402
-5,958
-2% -$244K 0.99% 34
2017
Q3
$14.1M Sell
320,360
-1,511
-0.5% -$52.6K 1.26% 20
2017
Q2
$8.74M Buy
321,871
+15,184
+5% +$376K 0.97% 36
2017
Q1
$6.94M Buy
306,687
+37,988
+14% +$786K 0.93% 42
2016
Q4
$5.76M Sell
268,699
-8,568
-3% -$184K 0.79% 57
2016
Q3
$6.13M Buy
277,267
+10,903
+4% +$233K 1.09% 36
2016
Q2
$4.76M Buy
266,364
+8,338
+3% +$144K 0.92% 48
2016
Q1
$4.45M Buy
258,026
+11,822
+5% +$198K 0.89% 49
2015
Q4
$5.22M Buy
246,204
+64,331
+35% +$1.31M 1.06% 35
2015
Q3
$3.43M Buy
181,873
+37,954
+26% +$812K 0.84% 54
2015
Q2
$3.3M Buy
143,919
+48,934
+52% +$1.14M 0.75% 64
2015
Q1
$2.56M Buy
94,985
+34,543
+57% +$881K 0.8% 58
2014
Q4
$1.75M Buy
+60,442
New +$1.64M 0.88% 59

Other funds holding QDEL

Aristotle Capital Boston's QDEL Position: Q1 2026 in Review

Aristotle Capital Boston increased its QuidelOrtho (QDEL) stake by 7.3% in Q1 2026, buying an estimated $700K and bringing the position to 420,402 shares worth $6.93M. The position accounts for 0.43% of the portfolio, ranked #92.

Aristotle Capital Boston first reported a position in QDEL in Q4 2014 and has held it in 46 quarters since. The position peaked at $70.7M in Q2 2020. 237 funds tracked by Wall St. Rank hold QDEL as of Q1 2026.

  • Aristotle Capital Boston held 420,402 shares of QuidelOrtho worth $6.93M as of Q1 2026.
  • Aristotle Capital Boston bought 28,498 QuidelOrtho shares in Q1 2026, an estimated $700K.
  • QuidelOrtho made up 0.43% of Aristotle Capital Boston's portfolio in Q1 2026, its #92 holding.
  • Aristotle Capital Boston first reported a position in QuidelOrtho in Q4 2014 and has held it in 46 quarters since.
  • Aristotle Capital Boston's QuidelOrtho position peaked at $70.7M in Q2 2020.
  • 237 funds tracked by Wall St. Rank held QuidelOrtho as of Q1 2026.

Based on Aristotle Capital Boston's 13F filing for Q1 2026, filed 15 May 2026.